Recently, the National Eye Institute revised its long-term strategic plan to include programs focused on a single “Audacious Goal” -- to regenerate lost or damaged retinal and optic nerve tissues and their connections in the brain.
While most glaucoma patients take at least one eye drop to control eye pressure, as many as 40% of patients need more than one medication. The more medications a patient takes the more likely he/she is to have adverse symptoms from preservatives.
Glaucoma Research Foundation provides seed money for creative pilot research projects that hold promise. We consider it vital to invest funds in new high-impact research that may lead to major government and philanthropic support.